Online inquiry

IVTScrip™ mRNA-Human ANXA2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17958MR)

This product GTTS-WK17958MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANXA2 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001002857.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 302
UniProt ID P07355
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANXA2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17958MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK2058MR IVTScrip™ mRNA-Human CD8, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA CD8
GTTS-WK7019MR IVTScrip™ mRNA-Human CD85d, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA CD85d
GTTS-WK1622MR IVTScrip™ mRNA-Human CD85k, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD85k
GTTS-WK3404MR IVTScrip™ mRNA-Human CD1d, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA CD1d
GTTS-WK3262MR IVTScrip™ mRNA-Human CD21, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA CD21
GTTS-WK6984MR IVTScrip™ mRNA-Human FMC7, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA FMC7
GTTS-WK19458MR IVTScrip™ mRNA-Human ANXA2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANXA2
GTTS-WK6105MR IVTScrip™ mRNA-Human CD226, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CD226
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →